Tag: Turning Point
Bristol-Myers To Buy Drug Developer Turning Point For $4.1B
Bristol Myers Squibb said on Friday it will acquire drug developer Turning Point Therapeutics for $4.1 billion in cash to help bolster its arsenal...
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.